SPDR S&P Biotech ETF $XBI Shares Acquired by Cary Street Partners Financial LLC

Cary Street Partners Financial LLC increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 36.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 14,993 shares of the exchange traded fund’s stock after purchasing an additional 3,995 shares during the quarter. Cary Street Partners Financial LLC’s holdings in SPDR S&P Biotech ETF were worth $1,828,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. AQR Capital Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 77.1% in the 1st quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after purchasing an additional 2,167 shares during the period. Marshall Wace LLP raised its holdings in shares of SPDR S&P Biotech ETF by 102.3% in the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after purchasing an additional 179,029 shares during the period. The Manufacturers Life Insurance Company purchased a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter worth about $260,000. Ameriprise Financial Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 123.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 3.7% in the 2nd quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after purchasing an additional 193 shares during the period.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $135.99 on Friday. SPDR S&P Biotech ETF has a 12 month low of $78.06 and a 12 month high of $139.19. The company has a market cap of $8.68 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The stock’s 50-day moving average is $130.68 and its 200-day moving average is $125.86.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.